Treatment of smc mediated disease
AssigneesSingapore Health Services Pte Ltd, National University of Singapore
InventorsStuart Alexander Cook, Sebastian Schaefer, Wei Wen Lim, Benjamin Wei Ming Ng
Life of this patent
Estimating the term…
Abstract
Diagnosis, treatment and prophylaxis of diseases and conditions associated with smooth muscle cell (SMC) dysfunction are provided through the inhibition of IL-11-mediated signalling.
Claims25
1-2. (canceled)
A method of treating or preventing a disease in which smooth muscle cells (SMCs) are pathologically implicated, the method comprising administering to a subject in need of treatment a therapeutically effective amount of an agent capable of inhibiting interleukin 11 (IL-11)-mediated signalling.
(canceled)
17-18. (canceled)
A method for inhibiting the activity of smooth muscle cells (SMCs) in a subject, the method comprising administering an agent capable of inhibiting interleukin 11 (IL-11)-mediated signalling to the subject.
24-25. (canceled)
28-41. (canceled)
Dependencies are inferred from the claim text.